X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   MYLAN
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
MYLAN
Dec-14
JUBILANT LIFE SCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1873,819-   
Low Rs652,691-   
Sales per share (Unadj.) Rs364.31,307.2-  
Earnings per share (Unadj.) Rs6.8157.5-  
Cash flow per share (Unadj.) Rs24.5253.5-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9649.8-  
Shares outstanding (eoy) m159.28378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 13.9%   
Avg P/E ratio x18.420.7 89.0%  
P/CF ratio (eoy) x5.112.8 40.0%  
Price / Book Value ratio x0.85.0 15.2%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0611,231,502 1.6%   
No. of employees `0006.225.0 24.7%   
Total wages/salary Rs m11,0520-   
Avg. sales/employee Rs Th9,383.019,784.8 47.4%   
Avg. wages/employee Rs Th1,786.90-   
Avg. net profit/employee Rs Th176.32,383.4 7.4%   
INCOME DATA
Net Sales Rs m58,034494,620 11.7%  
Other income Rs m191-2,883 -6.6%   
Total revenues Rs m58,224491,737 11.8%   
Gross profit Rs m5,786123,014 4.7%  
Depreciation Rs m2,81236,328 7.7%   
Interest Rs m3,23721,335 15.2%   
Profit before tax Rs m-7262,468 -0.1%   
Minority Interest Rs m-286-256 111.6%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6962,627 26.5%   
Profit after tax Rs m1,09059,585 1.8%  
Gross profit margin %10.024.9 40.1%  
Effective tax rate %-965.94.2 -22,969.1%   
Net profit margin %1.912.0 15.6%  
BALANCE SHEET DATA
Current assets Rs m29,280434,837 6.7%   
Current liabilities Rs m38,912339,955 11.4%   
Net working cap to sales %-16.619.2 -86.5%  
Current ratio x0.81.3 58.8%  
Inventory Days Days8478 108.1%  
Debtors Days Days51107 47.2%  
Net fixed assets Rs m55,712114,429 48.7%   
Share capital Rs m15517,491 0.9%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,265245,875 10.7%   
Long term debt Rs m17,169367,313 4.7%   
Total assets Rs m88,606990,362 8.9%  
Interest coverage x1.03.9 24.9%   
Debt to equity ratio x0.71.5 43.8%  
Sales to assets ratio x0.70.5 131.1%   
Return on assets %4.98.2 59.8%  
Return on equity %4.224.2 17.1%  
Return on capital %11.613.6 84.9%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,02665,018 12.3%  
From Investments Rs m-1,744-51,275 3.4%  
From Financial Activity Rs m-4,447-17,132 26.0%  
Net Cashflow Rs m1,834-3,389 -54.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 64.07 Rs / USD

Compare JUBILANT LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC LTD.  PIRAMAL ENTERPRISES  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views On News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 24, 2017 01:02 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS